SCHEMBL5178386

SCHEMBL5178386

NC(=O)c1cccnc1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.58
KDM4E B2RXH2 1/20 0.54
KCNA5 P22460 3/20 0.49
KCNH2 Q12809 1/20 0.49
RORB Q92753 5/20 0.48
RORC P51449 1/20 0.48
LMNA P02545 2/20 0.48
MEN1 O00255 1/20 0.48
GMNN O75496 1/20 0.48
ALDH1A1 P00352 1/20 0.48
TTR P02766 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.48
UGT1A1 P22309 1/20 0.48
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48
PMP22 Q01453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9002267 0.89 RORB (0.56) PARP1KCNA5KCNH2RORBRORC
SCHEMBL473595 0.87 ALDH1A1 (0.59) PARP1KDM4EKCNA5KCNH2RORB
SCHEMBL2565096 0.86 KIF11 (0.45) PARP1KDM4ERORBLMNAALDH1A1
SCHEMBL5665026 0.84 TRPV1 (0.52) PARP1
SCHEMBL10429353 0.84 KDM4E (0.55) PARP1KDM4ERORBRORCKMO
SCHEMBL2991676 0.81 LMNA (0.57) PARP1KDM4ERORBLMNATDP1
SCHEMBL3476293 0.81 AURKA (0.44) PARP1KDM4ELMNAMEN1GMNN
SCHEMBL6174664 0.80 KCNA5 (0.49) KCNA5KCNH2DHODHRPS6KB1
SCHEMBL4724483 0.79 PARP1 (0.59) PARP1KDM4ERORBRORCALDH1A1
SCHEMBL27964788 0.78 RORB (0.68) PARP1KCNA5RORBALDH1A1RPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed
EP-1807416-A1 NICOTINAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS Bayer Schering Pharma Aktiengesellschaft (DE) 2007-07-18 EP disclosed
WO-2006048249-A1 NICOTINAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2006-05-11 WO disclosed